| Health Care Equipment & Supplies Industry | Healthcare Sector | Charles S. McKhann CEO | NASDAQ (NMS) Exchange | 03767D108 CUSIP |
| US Country | 202 Employees | - Last Dividend | 30 Dec 2016 Last Split | - IPO Date |
Apollo Endosurgery, Inc. is a prominent medical technology firm that focuses on the innovation, development, and commercialization of cutting-edge medical instruments. Established in 2005 and headquartered in Austin, Texas, the company specializes in providing sophisticated solutions that empower healthcare professionals to perform advanced endoscopic procedures effectively. The company’s extensive portfolio includes products designed for various medical applications, particularly in the fields of gastrointestinal health and weight management. Apollo Endosurgery, Inc. delivers its medical solutions to a wide range of healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, serving markets in the United States, Australia, Costa Rica, and several European countries.
The OverStitch and OverStitch Sx systems enable physicians to perform advanced endoscopic procedures through suturing and securing tissue approximation via a flexible endoscope. These systems allow for enhanced treatment options and are integral in complex gastrointestinal procedures.
Offered under multiple brands, including the BIB and Orbera365 Managed Weight Loss System, the Orbera system assists patients in weight management by reducing gastric capacity and slowing down the process of gastric emptying. This innovative solution leads to decreased food intake, thus aiding in weight loss efforts.
This suture-based device is designed to repair defects within both the upper and lower gastrointestinal tracts. The X-Tack system offers a reliable and effective solution for treating various gastrointestinal issues, enhancing patient outcomes.